ACBP/DBI plasma concentrations also correlate with composite scores that measure the severity of liver disease [27], as this applies to the NAFLD fibrosis score, which integrates four blood parameters (albumin, alanine transaminase [ALT], aspartate transaminase [AST], and platelet count) and three clinical parameters (age, body mass index [BMI], diabetes) [36], as well as to the FIB4 score, which only computes four parameters (age, ALT, AST, and platelet count) [37]. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.